Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)

Q: What does CUSIP 71722W107 represent in this 13F holders report?

CUSIP 71722W107 is the security identifier for PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q2 2022?

88 institutional investors reported PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 71722W107

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 78,837,943
Total 13F shares: 27,258,631
Share change: +1,606,013
Total reported value: $230,064,222
Price per share: $8.44
Number of holders: 88
Value change: +$9,335,400
Number of buys: 51
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 71722W107?
CUSIP 71722W107 identifies PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 71722W107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Frazier Life Sciences Management, L.P.	13F	Company	7.4%	5,827,415	$79,311,000	—	31 Mar 2022	13F
Medicxi Ventures Management (Jersey) Ltd	13F	Company	2.6%	2,067,861	$28,143,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	2.6%	2,049,759	$27,897,000	—	31 Mar 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.5%	2,001,442	$27,238,000	—	31 Mar 2022	13F
Avidity Partners Management LP	13F	Company	2.5%	1,946,000	$26,485,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	2.5%	1,942,701	$26,441,000	—	31 Mar 2022	13F
Abingworth LLP	13F	Company	1.8%	1,435,106	$19,503,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	1.7%	1,378,517	$18,761,000	—	31 Mar 2022	13F
Ensign Peak Advisors, Inc	13F	Company	1.4%	1,104,759	$15,036,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.84%	660,690	$8,991,991	—	31 Mar 2022	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.71%	556,293	$7,571,000	—	31 Mar 2022	13F
GW&K Investment Management, LLC	13F	Company	0.61%	479,642	$6,528,000	—	31 Mar 2022	13F
StepStone Group LP	13F	Company	0.54%	422,085	$5,745,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.46%	365,044	$4,968,000	—	31 Mar 2022	13F
683 Capital Management, LLC	13F	Company	0.45%	355,000	$4,833,000	—	31 Mar 2022	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.43%	336,223	$4,576,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.4%	313,817	$4,271,000	—	31 Mar 2022	13F
Rhenman & Partners Asset Management AB	13F	Company	0.3%	235,210	$3,201,000	—	31 Mar 2022	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.26%	206,607	$2,812,000	—	31 Mar 2022	13F
MPM BioImpact LLC	13F	Company	0.25%	193,326	$2,631,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.23%	178,810	$2,433,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.22%	175,562	$2,389,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.16%	126,187	$1,718,000	—	31 Mar 2022	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.13%	102,328	$1,393,000	—	31 Mar 2022	13F
Penn Mutual Asset Management	13F	Company	0.11%	86,940	$1,183,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.11%	84,584	$1,151,000	—	31 Mar 2022	13F
Ikarian Capital, LLC	13F	Company	0.1%	78,550	$1,069,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.09%	73,649	$1,002,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.08%	66,658	$908,000	—	31 Mar 2022	13F
SEI INVESTMENTS CO	13F	Company	0.08%	66,641	$907,000	—	31 Mar 2022	13F
Parkman Healthcare Partners LLC	13F	Company	0.08%	65,553	$892,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.08%	61,288	$834,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.08%	61,581	$823,000	—	31 Mar 2022	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.06%	51,052	$695,000	—	31 Mar 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	0.06%	48,415	$659,000	—	31 Mar 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.06%	44,300	$603,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.05%	40,216	$547,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.05%	38,000	$517,000	—	31 Mar 2022	13F
Summit Rock Advisors, LP	13F	Company	0.04%	34,100	$464,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.04%	33,400	$455,000	—	31 Mar 2022	13F
CHARTWELL INVESTMENT PARTNERS, LLC	13F	Company	0.04%	30,590	$416,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	28,337	$386,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	0.03%	24,352	$330,000	—	31 Mar 2022	13F
PDT Partners, LLC	13F	Company	0.03%	21,200	$289,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	20,625	$281,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	19,968	$272,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	14,569	$198,000	—	31 Mar 2022	13F
MetLife Investment Management, LLC	13F	Company	0.02%	12,302	$167,430	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.01%	11,700	$159,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	11,541	$157,000	—	31 Mar 2022	13F

Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) as of Q2 2022

As of 30 Jun 2022, Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,258,631 shares. The largest 10 holders included Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Invesco Ltd., Avidity Partners Management LP, VANGUARD GROUP INC, Ensign Peak Advisors, Inc, BlackRock Inc., 683 Capital Management, LLC, Abingworth LLP, and JANUS HENDERSON GROUP PLC. This page lists 88 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.